Calamos Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.6M | Buy |
75,496
+5,748
| +8% | +$2.05M | 0.09% | 228 |
|
|
2025
Q4 | $22.8M | Sell |
69,748
-2,821
| -4% | -$895K | 0.09% | 241 |
|
|
2025
Q3 | $20.5M | Buy |
72,569
+244
| +0.3% | +$70.8K | 0.08% | 273 |
|
|
2025
Q2 | $20.2M | Hold |
72,325
| – | – | 0.08% | 266 |
|
|
2025
Q1 | $22.5M | Buy |
72,325
+840
| +1% | +$248K | 0.1% | 234 |
|
|
2024
Q4 | $18.6M | Hold |
71,485
| – | – | 0.08% | 271 |
|
|
2024
Q3 | $23M | Sell |
71,485
-1,814
| -2% | -$593K | 0.1% | 238 |
|
|
2024
Q2 | $22.9M | Sell |
73,299
-2,673
| -4% | -$785K | 0.1% | 230 |
|
|
2024
Q1 | $21.6M | Sell |
75,972
-1,909
| -2% | -$559K | 0.1% | 238 |
|
|
2023
Q4 | $22.4M | Sell |
77,881
-1,016
| -1% | -$277K | 0.11% | 231 |
|
|
2023
Q3 | $21.2M | Sell |
78,897
-32
| -0% | -$7.99K | 0.11% | 228 |
|
|
2023
Q2 | $17.5M | Sell |
78,929
-48
| -0.1% | -$11.1K | 0.09% | 283 |
|
|
2023
Q1 | $19.1M | Sell |
78,977
-9,862
| -11% | -$2.42M | 0.09% | 269 |
|
|
2022
Q4 | $23.3M | Sell |
88,839
-15,682
| -15% | -$4.2M | 0.11% | 239 |
|
|
2022
Q3 | $23.6M | Hold |
104,521
| – | – | 0.11% | 225 |
|
|
2022
Q2 | $25.4M | Buy |
104,521
+2,903
| +3% | +$711K | 0.11% | 220 |
|
|
2022
Q1 | $24.6M | Buy |
101,618
+13,589
| +15% | +$3.12M | 0.09% | 248 |
|
|
2021
Q4 | $19.8M | Buy |
88,029
+3,408
| +4% | +$719K | 0.07% | 280 |
|
|
2021
Q3 | $18M | Buy |
84,621
+7,467
| +10% | +$1.72M | 0.08% | 272 |
|
|
2021
Q2 | $18.8M | Buy |
77,154
+17,549
| +29% | +$4.32M | 0.09% | 263 |
|
|
2021
Q1 | $14.8M | Buy |
59,605
+1,842
| +3% | +$440K | 0.08% | 265 |
|
|
2020
Q4 | $13.3M | Sell |
57,763
-47,158
| -45% | -$10.9M | 0.08% | 274 |
|
|
2020
Q3 | $26.7M | Sell |
104,921
-5,289
| -5% | -$1.31M | 0.17% | 151 |
|
|
2020
Q2 | $26M | Sell |
110,210
-4,270
| -4% | -$974K | 0.18% | 150 |
|
|
2020
Q1 | $23.2M | Sell |
114,480
-44,917
| -28% | -$9.81M | 0.18% | 163 |
|
|
2019
Q4 | $38.4M | Sell |
159,397
-1,241
| -0.8% | -$274K | 0.19% | 149 |
|
|
2019
Q3 | $31.1M | Buy |
160,638
+90,392
| +129% | +$17.4M | 0.17% | 173 |
|
|
2019
Q2 | $12.9M | Buy |
70,246
+9,777
| +16% | +$1.75M | 0.07% | 297 |
|
|
2019
Q1 | $11.5M | Sell |
60,469
-436
| -0.7% | -$83.3K | 0.07% | 290 |
|
|
2018
Q4 | $11.9M | Sell |
60,905
-41,681
| -41% | -$8.13M | 0.08% | 276 |
|
|
2018
Q3 | $21.3M | Sell |
102,586
-21,772
| -18% | -$4.29M | 0.12% | 214 |
|
|
2018
Q2 | $23M | Sell |
124,358
-16,606
| -12% | -$2.94M | 0.14% | 199 |
|
|
2018
Q1 | $24M | Sell |
140,964
-61,186
| -30% | -$11.2M | 0.16% | 188 |
|
|
2017
Q4 | $35.2M | Sell |
202,150
-11,860
| -6% | -$2.1M | 0.18% | 121 |
|
|
2017
Q3 | $39.9M | Sell |
214,010
-15,801
| -7% | -$2.8M | 0.31% | 96 |
|
|
2017
Q2 | $39.6M | Buy |
229,811
+138,852
| +153% | +$22.6M | 0.29% | 93 |
|
|
2017
Q1 | $14.9M | Sell |
90,959
-183
| -0.2% | -$30.4K | 0.12% | 229 |
|
|
2016
Q4 | $13.3M | Sell |
91,142
-4,324
| -5% | -$651K | 0.11% | 226 |
|
|
2016
Q3 | $15.9M | Buy |
95,466
+79
| +0.1% | +$13.4K | 0.11% | 218 |
|
|
2016
Q2 | $14.5M | Buy |
95,387
+30
| +0% | +$4.66K | 0.1% | 232 |
|
|
2016
Q1 | $14.3M | Buy |
95,357
+5,049
| +6% | +$750K | 0.09% | 228 |
|
|
2015
Q4 | $14.7M | Buy |
90,308
+1,400
| +2% | +$220K | 0.09% | 232 |
|
|
2015
Q3 | $12.3M | Buy |
88,908
+26
| +0% | +$4.1K | 0.08% | 242 |
|
|
2015
Q2 | $13.6M | Sell |
88,882
-4,281
| -5% | -$686K | 0.08% | 235 |
|
|
2015
Q1 | $14.9M | Buy |
93,163
+47
| +0.1% | +$7.4K | 0.09% | 221 |
|
|
2014
Q4 | $14.8M | Buy |
93,116
+416
| +0.4% | +$64.8K | 0.1% | 219 |
|
|
2014
Q3 | $13M | Hold |
92,700
| – | – | 0.09% | 225 |
|
|
2014
Q2 | $11M | Buy |
92,700
+30,700
| +50% | +$3.55M | 0.07% | 244 |
|
|
2014
Q1 | $7.65M | Hold |
62,000
| – | – | 0.05% | 269 |
|
|
2013
Q4 | $7.08M | Hold |
62,000
| – | – | 0.05% | 278 |
|
|
2013
Q3 | $6.94M | Sell |
62,000
-485,175
| -89% | -$52.6M | 0.04% | 269 |
|
|
2013
Q2 | $54M | Buy |
+547,175
| New | +$56.8M | 0.35% | 76 |
|
Other funds holding AMGN
VCM
VPM
Calamos Advisors's AMGN Position: Q1 2026 in Review
Calamos Advisors increased its Amgen (AMGN) stake by 8.2% in Q1 2026, buying an estimated $2.05M and bringing the position to 75,496 shares worth $26.6M. The position accounts for 0.09% of the portfolio, ranked #228.
Calamos Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $54M in Q2 2013. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Calamos Advisors held 75,496 shares of Amgen worth $26.6M as of Q1 2026.
- Calamos Advisors bought 5,748 Amgen shares in Q1 2026, an estimated $2.05M.
- Amgen made up 0.09% of Calamos Advisors's portfolio in Q1 2026, its #228 holding.
- Calamos Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Calamos Advisors's Amgen position peaked at $54M in Q2 2013.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.